Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
Status:
Terminated
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if by giving a combination of 3 drugs the leukemia
will go into complete remission (meaning the leukemia is completely gone), and to find out
how long it stays away. The drugs used in this project are FDA approved and commercially
available.
Phase:
Phase 2
Details
Lead Sponsor:
Elizabeth Henry
Treatments:
Azacitidine Cholecalciferol Deferasirox Vitamin D Vitamins